Change in the Level of Vaccine Protection Over Time in COVID-19 Vaccinated Individuals: A Rapid Review
Public Health Agency of Canada
Cynthia Lisée, Emilie Rufray
Keven Joyal-Desmarais, Ariany M Vieira
- Canadian Institutes of Health Research (CIHR) through COVID-END
To identify, appraise, and summarise emerging research evidence to support evidence-informed decision making and answer the question: How does the level of vaccine protection, including effectiveness against asymptomatic and symptomatic infection, and severe outcomes change over time in individuals who have received a complete primary COVID-19 vaccine series?
Dr. Bacon’s research deals with the impact of health behaviours and lifestyle (e.g., physical activity, diet, weight management, stress) on the development and progression of chronic diseases (e.g., obesity, cardiovascular disease, COVID-19). He utilises multiple methodologies including epidemiological, psychophysiological, evidence syntheses, and behavioural trials designs. Currently, Dr. Bacon is the FRQS co-Chair in Artificial Intelligence and Digital Health for Health Behaviour Change and the CIHR SPOR Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials. He is also a fellow of the Obesity Society, the Canadian Cardiovascular Society, and the Academy of Behavioral Medicine Research. In addition to Concordia, Dr. Bacon is co-director of the Montreal Behavioural Medicine Centre (www.mbmc-cmcm.ca), a researcher at the Centre intégré universitaire de santé et de services sociaux du Nord-de-l’Île-de-Montréal (CIUSSS-NIM), and co-leads the International Behavioural Trials Network (www.IBTNetwork.org) and the CIHR funded Canadian Behavioural Interventions and Trials Network (www.CBITN.ca).
All outputs can also be found on the COVID-END Evidence Products webpage.